Chip-Based Blood Test Accurately Diagnoses Heart Attack in Minutes
By LabMedica International staff writers Posted on 17 Oct 2024 |

Heart attacks demand immediate medical attention to improve patient outcomes; however, while early diagnosis is crucial, it can be quite challenging—and nearly impossible outside of a clinical environment. Diagnosing heart attacks remains one of the most difficult tasks due to the wide variability of symptoms and subtle biological signals that can be easily overlooked in the early stages of an attack when medical intervention can be most beneficial. Individuals suspected of experiencing a heart attack typically undergo a series of tests to confirm the diagnosis, usually beginning with electrocardiograms that measure the heart's electrical activity—a procedure that takes about five minutes—and blood tests to identify the indicators of a heart attack, where lab results can take at least an hour and often require repetition. A new blood test has now been developed that can diagnose a heart attack in minutes rather than hours, and it has the potential to serve as a tool for first responders and individuals at home.
Researchers at Johns Hopkins University (Baltimore, MD, USA) have published their proof-of-concept work in Advanced Science, which can be modified to detect infectious diseases and cancer biomarkers. The focus of the research has been on developing diagnostic tools through biophotonics, utilizing laser light to identify biomarkers—bodily responses to various conditions, including diseases. In this instance, they applied the technology to detect the earliest signs in the blood that indicate a heart attack. The stand-alone blood test created by the team yields results in just five to seven minutes. They claim it is also more accurate and cost-effective than current methods.
Although initially designed for rapid diagnostic use in a clinical setting, the test could be adapted into a hand-held device for use by first responders in the field or even for personal use at home. Central to the invention is a small chip featuring a groundbreaking nanostructured surface for blood testing. The chip's "metasurface" amplifies electric and magnetic signals during Raman spectroscopy analysis, enabling heart attack biomarkers to be detected in seconds, even at ultra-low concentrations. This tool is sensitive enough to identify heart attack biomarkers that might not be detected by existing tests or might only be recognized later in the course of an attack. While primarily intended for diagnosing heart attacks, the researchers believe the tool could also be modified to detect cancer and infectious diseases. The team plans to refine the blood test further and undertake larger clinical trials in the future.
"We're talking about speed, we're talking about accuracy, and we're talking of the ability to perform measurements outside of a hospital," said Ishan Barman, Professor, Department of Mechanical Engineering. "In the future, we hope this could be made into a hand-held instrument like a Star Trek tricorder, where you have a drop of blood and then, voilà, in a few seconds you have detection."
Latest Technology News
- Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation
- Ultra-Sensitive Biosensor Based on Light and AI Enables Early Cancer Diagnosis
- Low-Cost Biosensing Technology Detects Disease Biomarkers in Minutes
- AI Tool Could Help Identify Specific Gut Bacterial Targets for Treatment of Diseases
- Inexpensive DNA Coated Electrode Paves Way for Disposable Diagnostics
- New Miniature Device to Transform Testing of Blood Cancer Treatments
- Biosensing Advancement to Enable Early Detection of Disease Biomarkers at POC
- New POC Biosensing Technology Improves Detection of Molecular Biomarkers
- Enhanced Lab Data Management and AI Critical to Labs of the Future, Finds Survey
- AI-Assisted Non-DNA Based Test Identifies Viral Infections in Minutes
- AI Method Predicts Overall Survival Rate of Prostate Cancer Patients
- Breath Test to Enable Early Detection of Breast Cancer
- First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels
- Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis
- Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
- Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Channels
Clinical Chemistry
view channel
New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read moreMolecular Diagnostics
view channel
DNA Methylation Signatures of Aging Could Help Assess Mortality Risk
Aging is associated with the progressive degeneration and loss of function across multiple physiological systems. Chronological age is the most common indicator of aging; however, there is significant... Read more
Molecular Diagnostics System Provides Lab-Quality Results at POC
Currently, there is a need for a comprehensive molecular diagnostics ecosystem that enables effective diagnostic stewardship, providing the diagnostic tools to offer the right tests, for the right patient,... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer
Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more
Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes
Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read moreMicrobiology
view channel
Viral Load Tests Can Help Predict Mpox Severity
Mpox is a viral infection that causes flu-like symptoms and a characteristic rash, which evolves significantly over time and varies between patients. The disease spreads mainly through direct contact with... Read more
Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. It significantly heightens the risk of... Read morePathology
view channel
AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care
Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
AI Tool Enhances Interpretation of Tissue Samples by Pathologists
Malignant melanoma, a form of skin cancer, is diagnosed by pathologists based on tissue samples. A crucial aspect of this process is estimating the presence of tumor-infiltrating lymphocytes (TILs), immune... Read more
AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease
Senescent cells, which stop growing and reproducing due to injury, aging, or disease, play a critical role in wound repair and aging-related diseases like cancer and heart disease. These cells, however,... Read more
Novel Fluorescent Probe Shows Potential in Precision Cancer Diagnostics and Fluorescence-Guided Surgery
Hepatocellular carcinoma (HCC), a common type of liver cancer, is difficult to diagnose early and accurately due to the limitations of current diagnostic methods. Glycans, carbohydrate structures present... Read moreIndustry
view channel
Quanterix Completes Acquisition of Akoya Biosciences
Quanterix Corporation (Billerica, MA, USA) has completed its previously announced acquisition of Akoya Biosciences (Marlborough, MA, USA), paving the way for the creation of the first integrated solution... Read more
Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
Lunit (Seoul, South Korea) and Microsoft (Redmond, WA, USA) have entered into a collaboration to accelerate the delivery of artificial intelligence (AI)-powered healthcare solutions. In conjunction with... Read more